Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059247) titled 'A clinical study of VisionGuard Pro nutritional jelly for slowing myopia progression in children' on Oct. 1.
Study Type: Interventional
Study Design:
Parallel Randomized
Primary Sponsor: Acikgoz LLC FZE
Condition:
Progressive myopia in children aged from 6 to 12 years
Intervention:
Arm 1 Intervention Name: VisionGuard Pro marine collagen nutritional jelly Type: Dietary supplement / nutritional product Dose &
regimen: 1 sachet (15 g) orally once daily for 12 weeks Packaging: Identical single-dose sachets
flavor/color matched to placebo Compliance: Sachet count and diary Concomitant restrictions: ...